Boston Children's Hospital has integrated artificial intelligence into its core operational and clinical infrastructure to reduce costs and diagnose rare medical conditions. By treating AI as a foundational layer rather than isolated tools, the hospital has enabled more than one-third of its staff to use the technology in daily tasks across research, clinical, and administrative roles. This system provides a secure internal environment that allows for rapid deployment of new capabilities, moving away from fragmented, one-off AI solutions.

Operational efficiency has been a primary focus, with the hospital automating repetitive tasks to address financial constraints and administrative burdens. AI systems now manage invoice intake and routing in the supply chain, while also optimizing surgical scheduling by analyzing clinical notes and patient acuity. These improvements have allowed for better allocation of operating room time and increased throughput. Across more than 50 active automations, the hospital reports approximately 60,000 hours in time savings, representing a value of over $7 million in redeployed labor.

In the clinical domain, Boston Children's has developed a tool described as a "co-pilot geneticist" to address the challenge of diagnosing rare diseases. This system synthesizes fragmented genetic data, patient phenotypic information (observable physical or biochemical characteristics), and global medical literature to assist physicians. This approach has led to the diagnosis of more than 40 rare conditions that were previously considered impossible to resolve, while also identifying new gene targets and potential therapeutic pathways.

The institution, which handles nearly 1 million outpatient visits annually across 40 specialties, plans to expand its AI strategy further. Future efforts will focus on deeper integration into clinical decision-making processes and broader adoption across all medical specialties. By collaborating with OpenAI to refine its models, the hospital aims to establish AI as an essential component of modern pediatric care, effectively augmenting the expertise of its physicians with synthesized medical knowledge.

Boston Children's Hospital has integrated artificial intelligence into its core operational and clinical infrastructure to reduce costs and diagnose rare medical conditions. By treating AI as a foundational layer rather than isolated tools, the hospital has enabled more than one-third of its staff to use the technology in daily tasks across research, clinical, and administrative roles. This system provides a secure internal environment that allows for rapid deployment of new capabilities, moving away from fragmented, one-off AI solutions.

Operational efficiency has been a primary focus, with the hospital automating repetitive tasks to address financial constraints and administrative burdens. AI systems now manage invoice intake and routing in the supply chain, while also optimizing surgical scheduling by analyzing clinical notes and patient acuity. These improvements have allowed for better allocation of operating room time and increased throughput. Across more than 50 active automations, the hospital reports approximately 60,000 hours in time savings, representing a value of over $7 million in redeployed labor.

In the clinical domain, Boston Children's has developed a tool described as a "co-pilot geneticist" to address the challenge of diagnosing rare diseases. This system synthesizes fragmented genetic data, patient phenotypic information (observable physical or biochemical characteristics), and global medical literature to assist physicians. This approach has led to the diagnosis of more than 40 rare conditions that were previously considered impossible to resolve, while also identifying new gene targets and potential therapeutic pathways.

The institution, which handles nearly 1 million outpatient visits annually across 40 specialties, plans to expand its AI strategy further. Future efforts will focus on deeper integration into clinical decision-making processes and broader adoption across all medical specialties. By collaborating with OpenAI to refine its models, the hospital aims to establish AI as an essential component of modern pediatric care, effectively augmenting the expertise of its physicians with synthesized medical knowledge.